找回密码
 立即注册
首页 Financial China 查看内容
  • QQ空间

China greenlights three IPOs on sci-tech innovation board

2020-1-5 17:18

 

BEIJING - China's securities regulator has given the nod to the registration-based initial public offerings (IPOs) of three companies on the science and technology innovation board.

Zhejiang Orient Gene Biotech Co Ltd, Shenzhen Neoway Technology Co Ltd and Suzhou Zelgen Biopharmaceuticals Co Ltd will be listed on the Shanghai Stock Exchange's sci-tech innovation board, commonly known as the STAR market, according to the China Securities Regulatory Commission.

It did not specify the total amount of funds to be raised.

The companies and their underwriters will confirm the IPO dates and publish their prospectuses following discussions with the stock exchange.

The STAR market, inaugurated in June and designed to support companies in the high-tech and strategic emerging sectors, eases the listing criteria but adopts higher requirements for information disclosure.

 

北京消息,中国证券监管机构已经批准了三家公司的首次公开募股(ipo)申请。


据中国证券监督管理委员会消息,浙江东方基因生物科技有限公司、深圳诺威科技有限公司和苏州泽尔根生物制药有限公司将在上海证券交易所的科技创新板块上市,该板块通常被称为“明星市场”。


声明没有具体说明将筹集的资金总额。


两家公司及其承销商将在与香港联合交易所讨论后,确认IPO日期并公布招股说明书。


“明星市场”于今年6月启动,旨在支持高科技和战略性新兴行业的公司。该市场放宽了上市标准,但对信息披露提出了更高的要求。

来自: xinhua